Abstract
Introduction The COVID-19 pandemic exposed many pregnant individuals to SARS-CoV-2. Literature suggests a link between gestational COVID-19 and adverse gestational outcomes. However, among all the factors that could impact pregnancy, COVID-19 is not the sole determinant, mainly in vulnerable populations. We hypothesized that COVID-19 could act as a moderator of some environmental exposures and pregnancy outcomes.
Methods To investigate this, our sample consisted of 120 pregnant individuals with or without a history of SARS-CoV-2 infection (moderator) and delivery complications (outcome). eXplainable Artificial Intelligence (XAI) was used to select the exposures from fifteen variables: trait and state anxiety, perceived stress in the past month, lifetime and gestational stressful events, body mass index, number of prenatal appointments, the violent crime rate in their area, belonging to a marginalized ethnic group, paternal and maternal age, income, education level, and employment. A moderation analysis evaluated whether COVID-19 exerted a moderator effect between the exposures and outcome.
Results XAI showed four variables that were associated with both pregnancy complications and COVID-19: trait anxiety, state anxiety, paternal age, and maternal age. These four variables were set as exposures in moderation analyses where COVID-19 was a moderator and gestation complications were the outcomes. COVID-19 interaction with the exposures was significant.
Discussion Our research suggests that being infected by SARS-CoV-2 exacerbates the effects of anxiety and parental age on susceptibility to adverse pregnancy outcomes. In other words, COVID-19 is a moderator for these variables, which should be accounted for in future studies.
What’s Known on This Subject?Infection by the virus SARS-CoV-2 causes the COVID-19 disease, which led to a worldwide pandemic. Pregnant people with COVID-19 have an increased risk of delivery complications such as preeclampsia. Other variables, such as mental health, also influence pregnancy outcomes.
What This Study Adds?Our sample showed no significant relationship between COVID-19 and delivery complications. However, COVID-19 interacted with anxiety and parental age to potentiate their effect on delivery complications. We suggest that COVID-19 worsens the challenges for young and anxious parents.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Sao Paulo Research Foundation (FAPESP grant #2022/11795-3) and by the European Union Horizon 2020 Research and Innovation Programme under ZIKAlliance (grant #734548). MLGK received scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Finance Code 001 and FAPESP (grant #2023/16277-3). CC was supported by FAPESP (grant #2021/00607-9). HB was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) #310823/2021-8. The Santos Dumont (SDumont) supercomputer was partially involved in the experiments.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee of the Hospital Universitario da Universidade de Sao Paulo (HU-USP) gave ethical approval for this work on 02/26/2021 (protocol 40160520.7.0000.0076). Our research conforms with the Brazilian General Personal Data Protection Law (13709/2018), which guarantees data privacy rights, and the World Medical Association Declaration of Helsinki. All the study subjects signed a consent form. No identifying information is published in any source.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail: marialgk{at}gmail.com, carolpcamilo{at}gmail.com, giselergouveia{at}gmail.com, helena.brentani{at}gmail.com, sergionery{at}gmail.com, lpbadaro55{at}gmail.com, julianakanezaki{at}gmail.com, thaiolivnog{at}gmail.com, jackegdt{at}yahoo.com.br, silviaibidi{at}hu.usp.br, alexandra{at}usp.br, dra.tatianecatharini{at}gmail.com, biancadasilvaleoni{at}gmail.com, rossana.francisco{at}hc.fm.usp.br, kethbiancolin{at}gmail.com, sabinoec{at}gmail.com, davidcmjr{at}gmail.com
Data availability
All the results are available in this manuscript and its supplementary material. The anonymized and processed dataset, as well as the scripts used for the analysis, are available at https://github.com/marialgk/PregnantCOVID/. More information can be obtained with the corresponding author upon request.
Abbreviations
- BMI
- Body Mass Index
- COVID-19
- Coronavirus Disease 2019
- DWLS
- Diagonally Weighted Least Squares
- HU-USP
- Hospital Universitario of São Paulo University
- PSS10
- Perceived Stress Scale (ten-item version)
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- SHAP
- SHapley Additive exPlanations
- STAI
- State-Trait Anxiety Inventory
- STAIS
- State anxiety
- STAIT
- Trait anxiety
- XAI
- eXplainable Artificial Intelligence
